NHS Wegovy treatment access
From: Robyn Gravestock (@RobynGravestock)
Following today’s NHS announcement on expanded Wegovy access, I have a dietitian & pharmacist available for comment on safe use, nutrition, managing side effects and patient support, as well as how these treatments impact heart health. Case studies also available #journorequest
Suggested angles
The practical realities of managing GLP-1 side effects: what patients need to know about nausea, appetite changes, and gastrointestinal adjustments
Nutritional considerations during Wegovy treatment: how dietitians help patients maintain adequate protein and micronutrient intake while losing weight
Cardiovascular benefits beyond weight loss: how these medications improve heart health markers and what that means for NHS patients with obesity-related conditions
Example quote
“Wegovy is most effective when combined with consistent nutritional support and realistic expectations about side effects—our role is ensuring patients stay engaged and safe throughout their treatment journey.”
Position your experts as translators of the science: focus on what expanded access means for real patient outcomes and the multidisciplinary support needed to make these treatments work safely.
Know someone perfect for this?
Share this page or forward the digest email.
Get opportunities like this daily
Subscribe to the SignalDesk digest — free and matched to your interests.
Subscribe at signaldesk.cc